Vaccine reduces shingles rate among elderly

Share this article:

Many seniors may soon be scratching and suffering less, thanks to a new shingles vaccine.

The Oka/Merck VZV vaccine decreases the occurrence rate and severity of shingles among older adults, and the pain that accompanies it, according to a report from the Shingles Prevention Study Group. Shingles occurs when a latent chickenpox virus is reactivated. It primarily affects older people, with about half developing complications according to last Thursday's New England Journal of Medicine.

Dr. Michael N. Oxman, at the VA San Diego Healthcare System, and colleagues tested the vaccine in 38,546 adults aged 60 and older. They took the vaccine or a placebo between 1998 and 2001 and were followed until April 2004.

After an average of three years, 315 cases occurred in the vaccine group and 642 in the placebo group. The vaccine also improved the severity of the illness, with an average duration of pain and discomfort of 21 days versus 24 days.

Share this article:

More in News

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...

Proposed managed care rule could accelerate shift away from nursing home care, official suggests

Proposed managed care rule could accelerate shift away ...

Proposed regulations slated for early 2015 likely will affect how Medicaid managed care balances home- versus facility-based long-term care, news sources reported Wednesday.

Assisted living residents say 'homelike' setting not so important

Contrary to conventional wisdom, assisted living residents might not place a high value on how "homelike" their surroundings are, suggest findings out of St. Catherine University in St. Paul, MN.